ClinicalTrials.Veeva

Menu

EUS-guided Choledochoduodenostomy for Primary Drainage of Malignant Distal Biliary Obstruction (SCORPION-II-p)

A

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Status

Enrolling

Conditions

Distal Cholangiocarcinoma
Biliary Obstruction
Pancreas Neoplasm

Treatments

Device: EUS-CDS

Study type

Interventional

Funder types

Other

Identifiers

NCT05595122
NL81840.029.22

Details and patient eligibility

About

A prospective single-centre pilot study investigating the feasibility and safety of EUS-guided choledochostomy as primary drainage strategy in patients with distal malignant biliary obstruction using a FCSEMS through LAMS to reduce stent dysfunction.

Enrollment

25 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Radiographically (CT or EUS) distal malignant bile duct obstruction
  • Histology or cytology proven malignancy of the primary tumour or metastasis; onsite cytology evaluation after EUS guided fine-needle sampling that is highly suspected of a malignancy suffices
  • Indication for biliary drainage; in case of a resectable tumour this should be discussed during a clinical multidisciplinary meeting
  • Written informed consent

Exclusion criteria

  • Age < 18 year

  • Surgically altered anatomy after previous gastric, periampullary or duodenal resection

  • Cancer extending into the antrum or proximal duodenum

  • Extensive liver metastases

  • WHO performance score of 4 (in bed 100% of time)

  • Uncorrectable coagulopathy, defined by INR>1.5 or platelets < 50 x 10^9/L*

  • Clinically relevant gastric-outlet obstruction

  • Unable to complete sign informed consent

    • Inclusion is allowed after corrective treatment measures are taken, according to local protocol and treating physician.

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

25 participants in 1 patient group

Intervention
Experimental group
Description:
EUS-CDS using FCSEMS through LAMS
Treatment:
Device: EUS-CDS

Trial contacts and locations

1

Loading...

Central trial contact

Jeska Fritzsche

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems